Imaging Activated Macrophages in the Lungs
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2018
Price : $35 *
At a glance
- Drugs Gallium-68-EC-2115 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Diagnostic use
- 31 Aug 2018 Status changed from not yet recruiting to recruiting.
- 01 May 2018 Planned initiation date changed from 15 Apr 2018 to 15 Jun 2018.
- 17 Apr 2018 New trial record